GEN İlaç ve Sağlık Ürünleri A.Ş.
3 clinical trials · Sponsor
◉ Watch GEN İlaç ve Sağlık Ürünleri A.Ş.
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease (NCT07322887) | GEN İlaç ve Sağlık Ürünleri A.Ş. | 2026-05-21 |
| A First-In-Human Study of Single and Multiple Ascending Doses of Oral SUL-238 in Healthy Subjects (NCT06277492) | GEN İlaç ve Sağlık Ürünleri A.Ş. | 2024-02-19 |
| Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis (NCT05706870) | GEN İlaç ve Sağlık Ürünleri A.Ş. | 2022-12-07 |
Track GEN İlaç ve Sağlık Ürünleri A.Ş. automatically
Every clearance here is in the API, with alerts when new ones post.